• Opinion
• [Reporter’s View] How to increase the new drug approval fee
• by Whang, byung-woo Sep 26, 2024 05:51am

• Policy
• Higher dosage Eylea expected to strike back at biosimilars
• by Lee, Tak-Sun Sep 26, 2024 05:51am

• Policy
• Potential expanded indication for obestiy drug 'Wegovy'
• by Lee, Hye-Kyung Sep 26, 2024 05:51am

• Product
• Zomig distributor changes from AZ to SK Chemicals
• by Kim JiEun Sep 25, 2024 05:49am

• Policy
• First generic version of Qudexy XR Cap is approved in KOR
• by Lee, Hye-Kyung Sep 25, 2024 05:49am

• Company
• "Bird flu: a new emerging pandemic risk factor"
• by Son, Hyung Min Sep 25, 2024 05:49am

• Company
• ‘Link the processes to improve access to orphan drugs'
• by Kim, Jin-Gu Sep 25, 2024 05:49am

• Policy
• Takeda's drug pricing negotiations see different results
• by Lee, Tak-Sun Sep 25, 2024 05:48am

• Company
• Cancer mRNA vaccine shows potential in brain tumor
• by Son, Hyung Min Sep 24, 2024 05:46am

• Company
• 'Keytruda' attempts at reimbursement for TNBC
• by Whang, byung-woo Sep 24, 2024 05:46am